Refine
Year of publication
Document Type
- Preprint (665)
- Article (385)
- Book (2)
- Conference Proceeding (1)
- Working Paper (1)
Has Fulltext
- yes (1054)
Is part of the Bibliography
- no (1054)
Keywords
- Heavy Ion Experiments (20)
- Hadron-Hadron Scattering (11)
- Hadron-Hadron scattering (experiments) (11)
- LHC (9)
- Heavy-ion collision (6)
- ALICE experiment (4)
- Collective Flow (4)
- Jets (4)
- Quark-Gluon Plasma (4)
- ALICE (3)
- COVID-19 (3)
- Heavy Ions (3)
- Jets and Jet Substructure (3)
- pp collisions (3)
- Beauty production (2)
- Bodensee (2)
- Bodensee-Gebiet (2)
- Charm physics (2)
- Experimental nuclear physics (2)
- Experimental particle physics (2)
- Heavy Quark Production (2)
- Konstanz (2)
- Landkreis Konstanz (2)
- Lepton-Nucleon Scattering (experiments) (2)
- Particle Correlations and Fluctuations (2)
- Particle and resonance production (2)
- Particle correlations and fluctuations (2)
- Pb–Pb collisions (2)
- QCD (2)
- SARS-CoV-2 (2)
- Single electrons (2)
- Tierökologie (2)
- influenza (2)
- out-patient paediatrics (2)
- respiratory tract infection (2)
- 1-propanol (1)
- 900 GeV (1)
- ALICE detector (1)
- Alcohol (1)
- Allergen immunotherapy (1)
- Allergoid (1)
- Anti-nuclei (1)
- Antiretroviral therapy (1)
- Antiretrovirals (1)
- Boosted Jets (1)
- Breast cancer (1)
- Breast tumors (1)
- Cancer detection and diagnosis (1)
- Cell binding (1)
- Cell staining (1)
- Centrality Class (1)
- Centrality Selection (1)
- Chemical composition (1)
- Cirrhosis (1)
- Collective Flow, (1)
- Comparison with QCD (1)
- Cumulative dose (1)
- Curvilinear dose response (1)
- Demolition emissions (1)
- Electron-pion identification (1)
- Electroweak interaction (1)
- Elliptic flow (1)
- European Union (1)
- European registry for idiopathic pulmonary fibrosis (eurIPFreg) (1)
- Femtoscopy (1)
- Fibre/foam sandwich radiator (1)
- Flohkrebse (1)
- Flow cytometry (1)
- Forschung (1)
- Genetic causes of cancer (1)
- Genetic testing (1)
- Grass pollen (1)
- HBT (1)
- HIV (1)
- HIV-1 (1)
- HNO (1)
- Hadron production (1)
- Hadron-Hadron Scattering Heavy (1)
- Hadron-hadron interactions (1)
- Hals-Nasen-Ohren-Heilkunde (1)
- Hard Scattering (1)
- Hazard assessment (1)
- Heavy Ion Experiment (1)
- Heavy flavor production (1)
- Heavy flavour production (1)
- Heavy ions (1)
- Heavy-flavour decay muons (1)
- Heavy-flavour production (1)
- Heavy-ion collisions (1)
- Hepatitis C virus (1)
- Hepatocellular carcinoma (1)
- Histology (1)
- Human genetics (1)
- Idiopathic pulmonary fibrosis (IPF) (1)
- Inclusive spectra (1)
- Intensity interferometry (1)
- Interstitial lung diseases (ILD) (1)
- Invariant Mass Distribution (1)
- Ionisation energy loss (1)
- Jet Physics (1)
- Jet Substructure (1)
- Kupffer cells (1)
- Lehre (1)
- Liver diseases (1)
- Liver transplantation (1)
- Macrophages (1)
- Material budget (1)
- Methanol (1)
- Method validation (1)
- Mid-rapidity (1)
- Minimum Bias (1)
- Monte Carlo (1)
- Mouse models (1)
- Multi-Parton Interactions (1)
- Multi-strange baryons (1)
- Multi-wire proportional drift chamber (1)
- Muscheln (1)
- Neural network (1)
- Nuclear modification factor (1)
- ORL (1)
- Oncology (1)
- Otorhinolaryngology (1)
- Ovarian cancer (1)
- PM10 (1)
- PYTHIA (1)
- Particle and Resonance Production (1)
- Pb–Pb (1)
- Post-offence drinking (1)
- Production Cross Section (1)
- Properties of Hadrons (1)
- Proton–proton (1)
- Quark Deconfinement (1)
- Quark Gluon Plasma (1)
- Quark Production (1)
- Quark gluon plasma (1)
- Quarkonium (1)
- Rapidity Range (1)
- Relativistic heavy ion physics (1)
- Relativistic heavy-ion collisions (1)
- Research (1)
- Residency (1)
- Resolution Parameter (1)
- Risk assessment (1)
- SARS-CoV‑2 pandemic (1)
- SARS-CoV‑2-Pandemie (1)
- See (1)
- Single muons (1)
- Size distribution (1)
- Specialist training (1)
- Sustainable chemistry (1)
- Systematic Uncertainty (1)
- TR (1)
- Teaching (1)
- Time Projection Chamber (1)
- Tracking (1)
- Transition radiation detector (1)
- Transverse momentum (1)
- Trigger (1)
- Ultrafine particles (1)
- University hospitals (1)
- Universitätskliniken (1)
- Urban aerosol (1)
- Vector Boson Production (1)
- Wasservögel (1)
- Weiterbildung (1)
- Xenon-based gas mixture (1)
- adenocarcinoma (1)
- allergen immunotherapy (1)
- birch pollen allergoid (1)
- central nervous system infection (1)
- cumulative dose (1)
- dE/dx (1)
- detector (1)
- diagnosis (1)
- dose response curve (1)
- experimental results (1)
- guideline (1)
- heavy ion experiments (1)
- immunocompromised patient (1)
- interferon regulatory factor 9 (IRF9) (1)
- lung cancer (1)
- quark gluon plasma (1)
- spectra (1)
- treatment (1)
- tumor microenvironment (TME) (1)
- type I interferons (IFNs) (1)
- versican (VCAN) (1)
- √sN N = 2.76 TeV (1)
Institute
- Physik (1025)
- Frankfurt Institute for Advanced Studies (FIAS) (955)
- Informatik (921)
- Medizin (19)
- Geowissenschaften (4)
- Informatik und Mathematik (3)
- Biowissenschaften (2)
- Hochschulrechenzentrum (2)
- Biochemie und Chemie (1)
- Center for Financial Studies (CFS) (1)
The analysis of ethanol and of its congeners in blood plays an important role in forensic cases, especially when allegations are made that alcohol has been consumed after an accident. In alcoholic beverages, congener alcohols are by-products and are generated during fermentation. The assay of these compounds in serum samples and beverages has been previously performed using headspace-gas chromatography-flame ionization detection methods (HS-GC-FID). As an alternative, a robust headspace-gas chromatography-mass spectrometry (HS-GC-MS) procedure was developed and validated, which has the following advantages:
- Simultaneous determination of ethanol, congener alcohols and other
endogenous substances.
- Reduction of matrix interference by increasing selectivity and
specificity.
- Clear separation of the positional isomers 3-methyl-1-butanol and
2-methyl-1-butanol.
TMEM70 is involved in the biogenesis of mitochondrial ATP synthase and mutations in the TMEM70 gene impair oxidative phosphorylation. Herein, we report on pathology and treatment of ATP synthase deficiency in four siblings. A consanguineous family of Roma (Gipsy) ethnic origin gave birth to 6 children of which 4 were affected presenting with dysmorphic features, failure to thrive, cardiomyopathy, metabolic crises, and 3-methylglutaconic aciduria as clinical symptoms. Genetic testing revealed a homozygous mutation (c.317-2A>G) in the TMEM70 gene. While light microscopy was unremarkable, ultrastructural investigation of muscle tissue revealed accumulation of swollen degenerated mitochondria with lipid crystalloid inclusions, cristae aggregation, and exocytosis of mitochondrial material. Biochemical analysis of mitochondrial complexes showed an almost complete ATP synthase deficiency. Despite harbouring the same mutation, the clinical outcome in the four siblings was different. Two children died within 60 h after birth; the other two had recurrent life-threatening metabolic crises but were successfully managed with supplementation of anaplerotic amino acids, lipids, and symptomatic treatment during metabolic crisis. In summary, TMEM70 mutations can cause distinct ultrastructural mitochondrial degeneration and almost complete deficiency of ATP synthase but are still amenable to treatment.
Objectives: The aim of this multicenter retrospective study was to investigate safety and efficacy of direct acting antiviral (DAA) treatment in the rare subgroup of patients with HCV/HIV-coinfection and advanced liver cirrhosis on the liver transplant waiting list or after liver transplantation, respectively.
Methods: When contacting 54 German liver centers (including all 23 German liver transplant centers), 12 HCV/HIV-coinfected patients on antiretroviral combination therapy were reported having received additional DAA therapy while being on the waiting list for liver transplantation (patient characteristics: Child-Pugh A (n = 6), B (n = 5), C (n = 1); MELD range 7–21; HCC (n = 2); HCV genotype 1a (n = 8), 1b (n = 2), 4 (n = 2)). Furthermore, 2 HCV/HIV-coinfected patients were denoted having received DAA therapy after liver transplantation (characteristics: HCV genotype 1a (n = 1), 4 (n = 1)).
Results: Applied DAA regimens were SOF/DAC (n = 7), SOF/LDV/RBV (n = 3), SOF/RBV (n = 3), PTV/r/OBV/DSV (n = 1), or PTV/r/OBV/DSV/RBV (n = 1), respectively. All patients achieved SVR 12, in the end. In one patient, HCV relapse occurred after 24 weeks of SOF/DAC therapy; subsequent treatment with 12 weeks PTV/r/OBV/DSV achieved SVR 12. One patient underwent liver transplantation while on DAA treatment. Analysis of liver function revealed either stable parameters or even significant improvement during DAA therapy and in follow-up. MELD scores were found to improve in 9/13 therapies in patients on the waiting list for liver transplantation; in only 2 patients a moderate increase of MELD scores persisted at the end of follow-up.
Conclusion: DAA treatment was safe and highly effective in this nation-wide cohort of patients with HCV/HIV-coinfection awaiting liver transplantation or being transplanted.